Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?

Literature DB >> 16000498

Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?

Bouke C de Jong¹, Anthony Onipede, Alex S Pym, Sebastien Gagneux, Roxanne S Aga, Kathryn DeRiemer, Peter M Small.

Abstract

Mycobacterium bovis is best identified by screening those isolates of the Mycobacterium tuberculosis complex that have any pyrazinamide (PZA) resistance, using a confirmatory test such as spoligotyping, biochemical testing, or genomic deletion analysis. The sensitivity for detection of M. bovis is lowered to 82% when only PZA-monoresistant isolates are screened.

Entities: Chemical Species

Mesh：

Substances：

Year: 2005 PMID： 16000498 PMCID： PMC1169118 DOI： 10.1128/JCM.43.7.3530-3532.2005

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

8 in total

1. Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis.

Authors: F Chaves; Z Yang; H el Hajj; M Alonso; W J Burman; K D Eisenach; F Dronda; J H Bates; M D Cave
Journal: J Clin Microbiol Date: 1996-05 Impact factor: 5.948

2. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Authors: M M Hannan; E P Desmond; G P Morlock; G H Mazurek; J T Crawford
Journal: J Clin Microbiol Date: 2001-02 Impact factor: 5.948

3. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors: J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal: J Clin Microbiol Date: 1993-02 Impact factor: 5.948

4. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997.

Authors: R M Jasmer; J A Hahn; P M Small; C L Daley; M A Behr; A R Moss; J M Creasman; G F Schecter; E A Paz; P C Hopewell
Journal: Ann Intern Med Date: 1999-06-15 Impact factor: 25.391

5. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors: J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal: J Clin Microbiol Date: 1997-04 Impact factor: 5.948

6. Use of multiple markers in population-based molecular epidemiologic studies of tuberculosis.

Authors: J T Rhee; M M Tanaka; M A Behr; C B Agasino; E A Paz; P C Hopewell; P M Small
Journal: Int J Tuberc Lung Dis Date: 2000-12 Impact factor: 2.373

7. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994-2000.

Authors: P A LoBue; W Betacourt; C Peter; K S Moser
Journal: Int J Tuberc Lung Dis Date: 2003-02 Impact factor: 2.373

8. A new evolutionary scenario for the Mycobacterium tuberculosis complex.

Authors: R Brosch; S V Gordon; M Marmiesse; P Brodin; C Buchrieser; K Eiglmeier; T Garnier; C Gutierrez; G Hewinson; K Kremer; L M Parsons; A S Pym; S Samper; D van Soolingen; S T Cole
Journal: Proc Natl Acad Sci U S A Date: 2002-03-12 Impact factor: 11.205

8 in total

15 in total

Review 1. Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.

Authors: N P Mnyambwa; D-J Kim; E S Ngadaya; R Kazwala; P Petrucka; S G Mfinanga
Journal: Eur J Clin Microbiol Infect Dis Date: 2017-06-07 Impact factor: 3.267

2. Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.

Authors: T A Thomas; S K Heysell; E R Houpt; J L Moore; S J Keller
Journal: Int J Tuberc Lung Dis Date: 2014-05 Impact factor: 2.373

3. Severe Enteropathy and Hypogammaglobulinemia Complicating Refractory Mycobacterium tuberculosis Complex Disseminated Disease in a Child with IL-12Rβ1 Deficiency.

Authors: Andrés Augusto Arias; Carlos M Perez-Velez; Julio César Orrego; Marcela Moncada-Velez; Jessica Lineth Rojas; Alejandra Wilches; Andrea Restrepo; Mónica Trujillo; Carlos Garcés; Catalina Arango-Ferreira; Natalia González; Carmen Oleaga-Quintas; Diana Fernández; Johana Marcela Isaza-Correa; Diego Eduardo Gongóra; Daniel Gonzalez-Loaiza; Juan Esteban Sierra; Jean Laurent Casanova; Jacinta Bustamante; José Luis Franco
Journal: J Clin Immunol Date: 2017-09-01 Impact factor: 8.317

4. Multiplex real-time PCR assay for rapid identification of Mycobacterium tuberculosis complex members to the species level.

Authors: Benjamin A Pinsky; Niaz Banaei
Journal: J Clin Microbiol Date: 2008-05-28 Impact factor: 5.948

Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?

1. Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis.

2. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

3. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

4. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997.

5. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

6. Use of multiple markers in population-based molecular epidemiologic studies of tuberculosis.

7. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994-2000.

8. A new evolutionary scenario for the Mycobacterium tuberculosis complex.

Review 1. Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.

2. Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.

3. Severe Enteropathy and Hypogammaglobulinemia Complicating Refractory Mycobacterium tuberculosis Complex Disseminated Disease in a Child with IL-12Rβ1 Deficiency.

4. Multiplex real-time PCR assay for rapid identification of Mycobacterium tuberculosis complex members to the species level.

5. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.

6. Gluteal abscess: An unusual complication of Bacille Calmette-Guérin.

7. Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California.

8. Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011.

9. Diagnostic challenges of central nervous system tuberculosis.

10. Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistance.